Many studies have described that DPPIV expression and activity is significantly altered in several solid tumor tissues and that these changes are associated with tumor grade, stage and patients 5-year survival, which point to this enzyme as a potential diagnostic tool and therapeutic target [12,13,15]. Here, DPP4 is linked to neoplasm.